Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-06
DOI
10.1038/s41581-021-00393-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A metabolomics based molecular pathway analysis for how the SGLT2‐inhibitor dapagliflozin may slow kidney function decline in patients with diabetes
- (2020) Skander Mulder et al. DIABETES OBESITY & METABOLISM
- Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors
- (2020) Christopher S. Wilcox HYPERTENSION
- SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
- (2020) Anton I. Korbut et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The tubular hypothesis of nephron filtration and diabetic kidney disease
- (2020) Volker Vallon et al. Nature Reviews Nephrology
- SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
- (2020) So Ra Kim et al. Nature Communications
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Autophagy in Chronic Kidney Diseases
- (2019) Tien-An Lin et al. Cells
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
- (2019) Hiddo J. L. Heerspink et al. DIABETOLOGIA
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
- (2019) Kengo Kidokoro et al. CIRCULATION
- Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
- (2019) Annabelle M. Warren et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Kidney Injury Molecule-1 Is Upregulated in Renal Lipotoxicity and Mediates Palmitate-Induced Tubular Cell Injury and Inflammatory Response
- (2019) Xueying Zhao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Direct effects of empagliflozin on extracellular matrix remodeling in human cardiac myofibroblasts: Novel translational clues to EMPA-REG OUTCOME
- (2019) Sean Kang et al. CANADIAN JOURNAL OF CARDIOLOGY
- Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial
- (2019) Atsushi Tanaka et al. DIABETES CARE
- Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
- (2019) Scott C. Thomson et al. AMERICAN JOURNAL OF MEDICINE
- The new biology of diabetic kidney disease - mechanisms and therapeutic implications
- (2019) Yuliya Lytvyn et al. ENDOCRINE REVIEWS
- Podocyte lipotoxicity in diabetic kidney disease
- (2019) Hiroshi Nishi et al. KIDNEY INTERNATIONAL
- The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
- (2019) Erik J.M. van Bommel et al. KIDNEY INTERNATIONAL
- Mechanism and Consequences of The Impaired Hif-1α Response to Hypoxia in Human Proximal Tubular HK-2 Cells Exposed to High Glucose
- (2019) Coral García-Pastor et al. Scientific Reports
- Testosterone Increases the Expression and Phosphorylation of AMP kinase α in Men with Hypogonadism and Type 2 Diabetes
- (2019) Husam Ghanim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
- (2018) Radica Z. Alicic et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- The Global Epidemiology of Diabetes and Kidney Disease
- (2018) Digsu N. Koye et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Update on Diabetic Nephropathy: Core Curriculum 2018
- (2018) Kausik Umanath et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Levels of Connective Tissue Growth Factor (CTGF) Predict Development of Kidney Dysfunction in Type 2 Diabetes-The VADT Study
- (2018) KELLY J. HUNT et al. DIABETES
- Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats
- (2018) Krit Jaikumkao et al. DIABETES OBESITY & METABOLISM
- Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers
- (2018) Claire C. J. Dekkers et al. DIABETES OBESITY & METABOLISM
- Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus
- (2018) Hussein Al Jobori et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
- (2018) Katherine R Tuttle et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Prediabetes is associated with microalbuminuria, reduced kidney function and chronic kidney disease in the general population
- (2018) M.R.P. Markus et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet
- (2018) Susumu Takagi et al. Journal of Diabetes Investigation
- Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: the potential contribution to diabetes complications and cardiovascular disease
- (2018) Fabrice Bonnet et al. DIABETES & METABOLISM
- Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways
- (2018) Habib Yaribeygi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition
- (2018) Sandor Koszegi et al. JOURNAL OF PHYSIOLOGY-LONDON
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts
- (2017) Tsung-Ming Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment
- (2017) Lennart Tonneijck et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice
- (2017) Hongyu Zhang et al. KIDNEY INTERNATIONAL
- Single-Nephron Glomerular Filtration Rate in Healthy Adults
- (2017) Aleksandar Denic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- High ratios of kidney function to kidney size are related to mortality and kidney function decline in high-risk patients
- (2017) Nicolette GC van der Sande et al. European Journal of Preventive Cardiology
- PGC1αActivators Mitigate Diabetic Tubulopathy by Improving Mitochondrial Dynamics and Quality Control
- (2017) So-Young Lee et al. Journal of Diabetes Research
- Obesity and Diabetic Kidney Disease: Role of Oxidant Stress and Redox Balance
- (2016) Kumar Sharma ANTIOXIDANTS & REDOX SIGNALING
- Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
- (2016) Ele Ferrannini et al. DIABETES
- The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels
- (2016) Simon A. Hawley et al. DIABETES
- Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis
- (2016) Sunder Mudaliar et al. DIABETES CARE
- SGLT2 Inhibitors and the Diabetic Kidney
- (2016) Paola Fioretto et al. DIABETES CARE
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes
- (2016) Giuseppe Daniele et al. DIABETES CARE
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
- (2016) James Voelker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2
- (2016) Michael J. Coady et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
- (2016) Xinfang Xie et al. LANCET
- Autophagy protects human podocytes from high glucose-induced injury by preventing insulin resistance
- (2016) Wei Xin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
- (2016) Ralph A. DeFronzo et al. Nature Reviews Nephrology
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- PGC-1α overexpression protects against aldosterone-induced podocyte depletion: role of mitochondria
- (2016) Min Zhao et al. Oncotarget
- JAK inhibition and progressive kidney disease
- (2015) Frank C. Brosius et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Mitochondrial Hormesis and Diabetic Complications: Figure 1
- (2015) Kumar Sharma DIABETES
- Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences
- (2015) Linda A Gallo et al. Diabetes & Vascular Disease Research
- Dapagliflozin Lowers Plasma Glucose Concentration and Improves β-Cell Function
- (2015) Aurora Merovci et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance
- (2015) Yu B.Y. Sun et al. KIDNEY INTERNATIONAL
- Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes
- (2015) Petter Bjornstad et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- New Insights Into Molecular Mechanisms of Diabetic Kidney Disease
- (2014) Shawn S. Badal et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
- (2014) Aurora Merovci et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
- (2014) Ele Ferrannini et al. JOURNAL OF CLINICAL INVESTIGATION
- Autophagy in diabetic nephropathy
- (2014) Yan Ding et al. JOURNAL OF ENDOCRINOLOGY
- Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles
- (2014) Kerri J. Grove et al. JOURNAL OF LIPID RESEARCH
- Functional Role of Glucose Metabolism, Osmotic Stress, and Sodium-Glucose Cotransporter Isoform-Mediated Transport on Na+/H+ Exchanger Isoform 3 Activity in the Renal Proximal Tubule
- (2014) T. D. Pessoa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Changes in Diabetes-Related Complications in the United States, 1990–2010
- (2014) Edward W. Gregg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
- (2014) Naoto Terami et al. PLoS One
- Renal “hyperfiltrators” are at elevated risk of death and chronic diseases
- (2014) Servet Altay et al. BMC Nephrology
- Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease
- (2014) Aiko P J de Vries et al. Lancet Diabetes & Endocrinology
- Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney
- (2013) Meenalakshmi M. Mariappan et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?
- (2013) G C Higgins et al. BRITISH JOURNAL OF PHARMACOLOGY
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- The Modern Spectrum of Renal Biopsy Findings in Patients with Diabetes
- (2013) S. G. Sharma et al. Clinical Journal of the American Society of Nephrology
- Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
- (2013) R. A. DeFronzo et al. DIABETES CARE
- Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
- (2013) Michal Herman-Edelstein et al. JOURNAL OF LIPID RESEARCH
- Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
- (2013) K. Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism
- (2013) Hanning You et al. KIDNEY INTERNATIONAL
- Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology
- (2013) Ming Zhan et al. KIDNEY INTERNATIONAL
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
- (2013) Usha Panchapakesan et al. PLoS One
- Emerging role of autophagy in kidney function, diseases and aging
- (2012) Tobias B. Huber et al. Autophagy
- The insulin receptor and the kidney
- (2012) Lorna J. Hale et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Oxidation of Fatty Acids Is the Source of Increased Mitochondrial Reactive Oxygen Species Production in Kidney Cortical Tubules in Early Diabetes
- (2012) M. G. Rosca et al. DIABETES
- Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
- (2012) P. Ruggenenti et al. DIABETES CARE
- Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice
- (2012) M. Y. Kim et al. DIABETOLOGIA
- Prediabetic Nephropathy as an Early Consequence of the High-Calorie/High-Fat Diet: Relation to Oxidative Stress
- (2012) Hanna Shevalye et al. ENDOCRINOLOGY
- Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases
- (2012) E. Morales et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The proximal tubule in the pathophysiology of the diabetic kidney
- (2011) Volker Vallon AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Increased NHE3 abundance and transport activity in renal proximal tubule of rats with heart failure
- (2011) Bruna H. Inoue et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat
- (2011) Scott C. Thomson et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Renal Function in Diabetic Disease Models: The Tubular System in the Pathophysiology of the Diabetic Kidney
- (2011) Volker Vallon et al. Annual Review of Physiology
- Transcriptome Analysis of Human Diabetic Kidney Disease
- (2011) K. I. Woroniecka et al. DIABETES
- Arginase-2 Mediates Diabetic Renal Injury
- (2011) Sidney M. Morris et al. DIABETES
- Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 Diabetes
- (2011) Munehiro Kitada et al. Experimental Diabetes Research
- Noninvasive Evaluation of Kidney Hypoxia and Fibrosis Using Magnetic Resonance Imaging
- (2011) T. Inoue et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mitochondrial Fission Contributes to Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle
- (2011) H.-F. Jheng et al. MOLECULAR AND CELLULAR BIOLOGY
- A modest decrease in endothelial NOS in mice comparable to that associated with humanNOS3variants exacerbates diabetic nephropathy
- (2011) Chih-Hong Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
- (2010) Gavin I. Welsh et al. Cell Metabolism
- Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
- (2010) S. G. Adler et al. Clinical Journal of the American Society of Nephrology
- The clinical significance of hyperfiltration in diabetes
- (2010) G. Jerums et al. DIABETOLOGIA
- Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans
- (2010) Bernhard Bielesz et al. JOURNAL OF CLINICAL INVESTIGATION
- Glucose-Induced Regulation of NHEs Activity and SGLTs Expression Involves the PKA Signaling Pathway
- (2010) Olívia Beloto-Silva et al. JOURNAL OF MEMBRANE BIOLOGY
- SRT1720 Induces Mitochondrial Biogenesis and Rescues Mitochondrial Function after Oxidant Injury in Renal Proximal Tubule Cells
- (2010) J. A. Funk et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
- (2010) G. Ortiz-Munoz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
- (2010) Faramarz Ismail-Beigi et al. LANCET
- Glucose-transporter–mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients
- (2010) Dirk von Lewinski et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Termination of autophagy and reformation of lysosomes regulated by mTOR
- (2010) Li Yu et al. NATURE
- The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease
- (2010) Imari Mimura et al. Nature Reviews Nephrology
- The RAAS in the pathogenesis and treatment of diabetic nephropathy
- (2010) Piero Ruggenenti et al. Nature Reviews Nephrology
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease
- (2010) Vincent Rigalleau et al. BMC Nephrology
- Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
- (2009) S. Zoungas et al. DIABETES CARE
- Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
- (2009) G. M. Magee et al. DIABETOLOGIA
- Role of Growth Factors in Diabetic Kidney Disease
- (2009) F. Chiarelli et al. HORMONE AND METABOLIC RESEARCH
- Impaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy
- (2009) L. M. Russo et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Adenosine A1 Receptors Determine Glomerular Hyperfiltration and the Salt Paradox in Early Streptozotocin Diabetes Mellitus
- (2009) Volker Vallon et al. NEPHRON PHYSIOLOGY
- Expression and Activity of SGLT2 in Diabetes Induced by Streptozotocin: Relationship with the Lipid Environment
- (2009) María F. Albertoni Borghese et al. NEPHRON PHYSIOLOGY
- Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
- (2008) C. C. Berthier et al. DIABETES
- Enhanced expressions of sodium–glucose cotransporters in the kidneys of diabetic Zucker rats
- (2008) Niloofar M. Tabatabai et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Glomerulotubular Balance, Tubuloglomerular Feedback, and Salt Homeostasis
- (2008) S. C. Thomson et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Aliskiren and Dual Therapy in Type 2 Diabetes Mellitus
- (2008) Julie R. Ingelfinger NEW ENGLAND JOURNAL OF MEDICINE
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptional Paradigms in Mammalian Mitochondrial Biogenesis and Function
- (2008) Richard C. Scarpulla PHYSIOLOGICAL REVIEWS
- The Role of chemokines and chemokine receptors in diabetic nephropathy
- (2007) Christiane Ruster Frontiers in Bioscience-Landmark
- Transforming growth factor-β/connective tissue growth factor axis in the kidney
- (2007) Weier Qi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Adaptation to hypoxia in the diabetic rat kidney
- (2007) C. Rosenberger et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More